At a recent event for pharmaceutical executives and biotech founders, Anthropic unveiled its newest product, Claude Science, designed to support scientific research. This move signals the company’s commitment to AI in the scientific field, particularly in computational biology and drug development. By allowing researchers to receive meaningful results from high-level instructions, Claude Science is expected to accelerate progress in these areas.

However, while California’s climate policies are receiving a fresh round of scrutiny, it appears that the state's approach may be flawed. A system paying cattle farmers to convert methane emissions into natural gas has become wildly popular due to lucrative subsidies. Yet research suggests this program exposes the shortcomings of carbon offsetting schemes, potentially locking in more warming.

The US has lifted restrictions on Anthropic’s Mythos and Fable models, allowing for broader access despite concerns over security. This move could open doors for Chinese AI rivals but also reinvigorate the field with new possibilities. The search for dark matter is being blown wide open by neutrinos, prompting researchers to cast a wider net in their hunt.

Meanwhile, billions of dollars are flowing into efforts to reverse aging, aiming to return cells to a younger state. The most detailed survey of the universe ever is underway using the largest digital camera on Earth, while tech talent is fleeing the US due to H1-B visa chaos. Trump reportedly raked in over $1 billion from crypto businesses.